Skip to main content


Log in

Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript


Pretreatment with quipazine, a serotonin agonist, and clomipramine, a selective serotonin neuronal uptake blocker, was found to potentiate the cataleptic effect of haloperidol in a dose-dependent manner in rats. Pretreatment with methysergide, a serotonin antagonist, reduced the cataleptic effect of haloperidol. The results indicate that the cataleptic effect of neuroleptics depends on the balance between the dopaminergic and serotonergic systems, and that the serotonergic system exerts an inhibitory influence on the dopaminergic system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others


  • Chase, T. N., Murphy, D. L.: Serotonin and central nervous system function. In: Annual review of pharmacology, vol 13. H. W. Elliot, R. Okun, and R. George, eds., pp. 181–197. California: Annual Reviews Inc. 1973

    Google Scholar 

  • Costall, B., naylor, R. J.: Stereotyped and circling behavior induced by dopaminergic agonists after lesions of the mid brain raphe nuclei. Eur. J. Pharmacol. 29, 206–222 (1974a)

    Google Scholar 

  • Costall, B., Naylor, R. J.: Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Eur. J. Pharmacol. 27, 46–58 (1974b)

    Google Scholar 

  • Franz, D. N.: Drugs for Parkinson's disease; centrally acting muscle relaxants. In: The pharmacological basis of therapeutics, L. S. Goodman and A. Gilman, eds., pp. 227–244. New York: Macmillan Publishing Co., Inc. 1975

    Google Scholar 

  • Hamon, M., Bourgoin, S., Enjaber, A., Bockaert, J., Hery, F., Ternaux, J. P., Glowinski, J.: The effects of quipazine on 5-HT metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 294, 99–108 (1976)

    Google Scholar 

  • Hong, E., Sancilio, L. F., Vargas, R., Pardo, E. G.: Similarities between the pharmacological actions of quipazine and serotonin. Eur. J. Pharmacol. 6, 274–280 (1969)

    Google Scholar 

  • Kostowski, W., Gumulka, W., Czlonkowski, A.: Reduced cataleptogenic effects of some neuroleptics in rats with lesioned mid brain raphe and treated with p-chlorophenylalanine. Brain Res. 48, 443–446 (1972)

    Google Scholar 

  • Malec, D., Langwinski, R., Kruszewska, A.: The role of 5-HT in the mechanism of amphetamine action. Pol. J. Pharmacol. Pharm. 27, 155–160 (1975)

    Google Scholar 

  • Mattysse, S.: Antipsychotic drug actions: a clue to the neuropathology of schizophrenia? Fed. Proc. 32, 200–205 (1973)

    Google Scholar 

  • Medon, P. J., Leeling, J. L., Phillips, B. M.: Influence of quipazine, a potential antiparkinsonian agent, on the uptake of 3H-dopamine and 3H-serotonin into rat striatal tissue in vitro. Life Sci. 13, 685–691 (1973)

    Google Scholar 

  • Parizek, J., Hassler, R., Bak, I. J.: Light and electron microscopic autoradiography of substantia nigra of rat after intraventricular administration of tritium labeled norepinephrine, serotonin, dopamine and the precursors. Z. Zellforsch. Mikrosk. Anat 115, 137–148 (1971)

    Google Scholar 

  • Pollin, W., Cardon, P. V., Kety, S.: Effects of amino acid feedings in schizophrenic patients treated with iproniazid. Science 133, 104–105 (1961)

    Google Scholar 

  • Rodriguez, R., Rojas-Ramirez, J. A., Drucker-Colin, R. R.: Serotonin-like actions of quipazine on the central nervous system. Eur. J. Pharmacol. 24, 164–171 (1973)

    Google Scholar 

  • Ross, S. B., Renyi, A. L.: Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3H-noradrenaline and 14C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. Acta Pharmacol. Toxicol. 36, 382–394 (1975)

    Google Scholar 

  • Ross, S. B., Renyi, A. L., Ogren, S. O.: Inhibition of the uptake of noradrenaline and 5-hydroxytryptamine by chlorphentermine and chlorimipramine. Eur. J. Pharmacol. 17, 107–112 (1972)

    Google Scholar 

  • Snyder, S. H., Banerjee, S. P., Yamamura, H. I., Greenberg, D.: Drugs, neurotransmitters, and schizophrenia. Science 184, 1243–1253 (1974)

    Google Scholar 

  • Wyatt, R. J., Vaughan, T., Galanter, M., Green, R., Kaplan, J.: Behavioral changes of chronic schizophrenic patients given l-5-hydroxytryptophan. Science 177, 1124–1126 (1972)

    Google Scholar 

Download references

Author information

Authors and Affiliations


Rights and permissions

Reprints and permissions

About this article

Cite this article

Balsara, J.J., Jadhav, J.H. & Chandorkar, A.G. Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy. Psychopharmacology 62, 67–69 (1979).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

Key words